These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34977367)

  • 21. Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study.
    Iivanainen S; Alanko T; Vihinen P; Konkola T; Ekstrom J; Virtanen H; Koivunen J
    JMIR Form Res; 2020 Oct; 4(10):e17898. PubMed ID: 33112242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Bruner DW; Hanisch LJ; Reeve BB; Trotti AM; Schrag D; Sit L; Mendoza TR; Minasian L; O'Mara A; Denicoff AM; Rowland JH; Montello M; Geoghegan C; Abernethy AP; Clauser SB; Castro K; Mitchell SA; Burke L; Trentacosti AM; Basch EM
    Transl Behav Med; 2011 Mar; 1(1):110-22. PubMed ID: 24073038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital Medicine in Men with Advanced Prostate Cancer - A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment.
    Appleyard SE; Larkin MJW; Stewart EM; Minton O; Gilbert DC
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):751-760. PubMed ID: 33966948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study.
    Iivanainen S; Alanko T; Peltola K; Konkola T; Ekström J; Virtanen H; Koivunen JP
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):765-774. PubMed ID: 30666409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany.
    Klüter S; Katayama S; Spindeldreier CK; Koerber SA; Major G; Alber M; Akbaba S; Debus J; Hörner-Rieber J
    Strahlenther Onkol; 2020 Aug; 196(8):691-698. PubMed ID: 32002567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events.
    Yoon J; Sim SH; Kang D; Han G; Kim Y; Ahn J; Oh D; Lee ES; Kong SY; Cho J; Mitchell SA
    J Pain Symptom Manage; 2020 May; 59(5):1082-1088.e6. PubMed ID: 32044423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Online Symptom Monitoring During Pelvic Radiation Therapy: Randomized Pilot Trial of the eRAPID Intervention.
    Holch P; Absolom KL; Henry AM; Walker K; Gibson A; Hudson E; Rogers Z; Holmes M; Peacock R; Pini S; Gilbert A; Davidson S; Routledge J; Murphy A; Franks K; Hulme C; Hewison J; Morris C; McParland L; Brown J; Velikova G
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):664-676. PubMed ID: 36241128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.
    Albaba H; Barnes TA; Veitch Z; Brown MC; Shakik S; Su S; Naik H; Wang T; Liang M; Perez-Cosio A; Eng L; Mittmann N; Xu W; Howell D; Liu G
    Oncologist; 2019 Nov; 24(11):e1219-e1227. PubMed ID: 31409744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac.
    Eijkelenkamp H; Grimbergen G; Daamen LA; Heerkens HD; van de Ven S; Mook S; Meijer GJ; Molenaar IQ; van Santvoort HC; Paulson E; Erickson BA; Verkooijen HM; Hall WA; Intven MPW
    Front Oncol; 2023; 13():1040673. PubMed ID: 37854684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of implementing a cervix cancer-specific patient-reported outcome measure in routine ambulatory clinics.
    Atallah S; Barbera L; Folwell M; Howell D; Liu Z; Croke J
    Support Care Cancer; 2021 Jan; 29(1):499-507. PubMed ID: 32405964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choice of a patient-reported outcome measure for patients with anal cancer for use in cancer clinical trials and routine clinical practice: a mixed methods approach.
    Gilbert A; Francischetto EO; Blazeby J; Holch P; Davidson S; Sebag-Montefiore D; Velikova G
    Lancet; 2015 Feb; 385 Suppl 1():S38. PubMed ID: 26312860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter Prospective Cohort Study of the Patient-Reported Outcome Measures PRO-CTCAE and CAT EORTC QLQ-C30 in Major Abdominal Cancer Surgery (PATRONUS): A Student-Initiated German Medical Audit (SIGMA) Study.
    ; Mihaljevic AL
    Ann Surg Oncol; 2021 Jun; 28(6):3075-3089. PubMed ID: 33683524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine-(TRACE).
    Dörner L; Grosse L; Stange F; Hille H; Kurz S; Becker H; Volkmer S; Hippler M; Rieger D; Bombach P; Rieger J; Weinert L; Svensson L; Anders C; Cekin S; Paulsen F; Öner Ö; Ruhm K; Malek HS; Möller Y; Tatagiba M; Wallwiener M; Eckert N; Escher P; Pfeifer N; Forschner A; Bauer A; Zips D; Bitzer M; Malek N; Gani C; Tabatabai G; Renovanz M
    Neurooncol Pract; 2024 Jun; 11(3):336-346. PubMed ID: 38737615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usability of Electronic Patient-Reported Outcome Measures for Older Patients With Cancer: Secondary Analysis of Data from an Observational Single Center Study.
    Riedl D; Lehmann J; Rothmund M; Dejaco D; Grote V; Fischer MJ; Rumpold G; Holzner B; Licht T
    J Med Internet Res; 2023 Sep; 25():e49476. PubMed ID: 37733409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery.
    Avery KNL; Richards HS; Portal A; Reed T; Harding R; Carter R; Bamforth L; Absolom K; O'Connell Francischetto E; Velikova G; Blazeby JM
    BMC Cancer; 2019 May; 19(1):463. PubMed ID: 31101017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol for a mixed-methods study to develop and feasibility test a digital system for the capture of patient-reported outcomes (PROs) in patients receiving chimeric antigen receptor T-cell (CAR-T) therapies (the PRO-CAR-T study).
    Hughes SE; McMullan C; Aiyegbusi OL; Shaw K; Kinsella F; Ferguson P; Khatsuria F; Burns D; Pyatt L; Ansell J; Chakera E; Richardson-Abraham J; Denniston AK; Davies EH; Craddock C; Calvert M
    BMJ Open; 2024 Mar; 14(3):e085392. PubMed ID: 38553074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy.
    Takala L; Kuusinen TE; Skyttä T; Kellokumpu-Lehtinen PL; Bärlund M
    Clin Breast Cancer; 2021 Jun; 21(3):e252-e270. PubMed ID: 33229222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient-reported outcome assessment for the Austrian Myelome Registry.
    Sztankay M; Neppl L; Wintner LM; Loth FL; Willenbacher W; Weger R; Weyrer W; Steurer M; Rumpold G; Holzner B
    Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13154. PubMed ID: 31465136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.